Paper35697668
Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa.
Silva JC and 13 others. Nat Commun, 2022. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. Papers, record 35697668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35697668
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria Vaccines | Major topic |
| Malaria, Falciparum | Major topic |
| Adult | |
| Africa | |
| Animals | |
| Epitopes, T-Lymphocyte | |
| Humans | |
| Plasmodium falciparum | |
| Sporozoites |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI141900 | NIAID NIH HHS | United States | R01AI141900 | PubMed and NIH | NIH RePORTER |
| R44 AI055229 | NIAID NIH HHS | United States | R44AI055229 | PubMed and NIH | NIH RePORTER |
| R44 AI058375 | NIAID NIH HHS | United States | R44AI058375 | PubMed and NIH | NIH RePORTER |
| U19 AI110820 | NIAID NIH HHS | United States | U19AI110820 | PubMed and NIH | NIH RePORTER |
| ZIAAI001170 | NIH | NIH RePORTER |
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33947856 | Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. | Nat Commun | 2021 | https://conductscience.org/library/papers/33947856 | PubMed |
| 2 | 23929949 | Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. | Science | 2013 | https://conductscience.org/library/papers/23929949 | PubMed |
| 3 | 18974882 | Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. | PLoS Pathog | 2008 | https://conductscience.org/library/papers/18974882 | PubMed |
| 4 | 9086149 | Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. | J Infect Dis | 1997 | https://conductscience.org/library/papers/9086149 | PubMed |
| 5 | 28216244 | Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. | Lancet Infect Dis | 2017 | https://conductscience.org/library/papers/28216244 | PubMed |
| 6 | 28719326 | Malaria-Related Hospitalizations in the United States, 2000-2014. | Am J Trop Med Hyg | 2017 | https://conductscience.org/library/papers/28719326 | PubMed |
| 7 | 17538895 | Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. | J Infect Dis | 2007 | https://conductscience.org/library/papers/17538895 | PubMed |
| 8 | 31419294 | Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults. | J Infect Dis | 2019 | https://conductscience.org/library/papers/31419294 | PubMed |
| 9 | 23060615 | A high-performance computing toolset for relatedness and principal component analysis of SNP data. | Bioinformatics | 2012 | https://conductscience.org/library/papers/23060615 | PubMed |
| 10 | 23325771 | Total and putative surface proteomics of malaria parasite salivary gland sporozoites. | Mol Cell Proteomics | 2013 | https://conductscience.org/library/papers/23325771 | PubMed |
| 11 | 27389903 | Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic. | MMWR Suppl | 2016 | https://conductscience.org/library/papers/27389903 | PubMed |
| 12 | 28199305 | Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. | Nature | 2017 | https://conductscience.org/library/papers/28199305 | PubMed |
| 13 | 32920641 | Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32920641 | PubMed |
| 14 | 28431816 | Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food & drug administration (FDA) perspective. | Vaccine | 2017 | https://conductscience.org/library/papers/28431816 | PubMed |
| 15 | 28223498 | Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28223498 | PubMed |
| 16 | 31782768 | Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31782768 | PubMed |
| 17 | 34801112 | Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/34801112 | PubMed |
| 18 | 21903775 | Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. | Science | 2011 | https://conductscience.org/library/papers/21903775 | PubMed |
| 19 | 29943719 | Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults. | Am J Trop Med Hyg | 2018 | https://conductscience.org/library/papers/29943719 | PubMed |
| 20 | 28903777 | Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial. | BMC Med | 2017 | https://conductscience.org/library/papers/28903777 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42611549 | Pan-African hybridization of PfSPZ increases antigenic diversity and replicative capacity for malaria vaccine design. | JCI Insight | 2026 | https://conductscience.org/library/papers/42611549 | PubMed |
| 41565496 | The endemic dilemma: why whole sporozoite malaria vaccine efficacy falls in the field. | Trends Parasitol | 2026 | https://conductscience.org/library/papers/41565496 | PubMed |
| 40098097 | Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection. | Malar J | 2025 | https://conductscience.org/library/papers/40098097 | PubMed |
| 39753973 | Setting sights on a single-shot malaria vaccine. | Nat Med | 2025 | https://conductscience.org/library/papers/39753973 | PubMed |
| 39025972 | Malaria vaccines: a new era of prevention and control. | Nat Rev Microbiol | 2024 | https://conductscience.org/library/papers/39025972 | PubMed |
| 38514791 | A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion. | EMBO Mol Med | 2024 | https://conductscience.org/library/papers/38514791 | PubMed |
| 37624021 | Malaria Genomics, Vaccine Development, and Microbiome. | Pathogens | 2023 | https://conductscience.org/library/papers/37624021 | PubMed |
| 37571809 | Sporozoite immunization: innovative translational science to support the fight against malaria. | Expert Rev Vaccines | 2023 | https://conductscience.org/library/papers/37571809 | PubMed |
| 37384799 | The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37384799 | PubMed |
| 36159849 | Five decades of clinical assessment of whole-sporozoite malaria vaccines. | Front Immunol | 2022 | https://conductscience.org/library/papers/36159849 | PubMed |
| 35999221 | A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35999221 | PubMed |
| 35928033 | PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial. | EClinicalMedicine | 2022 | https://conductscience.org/library/papers/35928033 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| DNAJC5 | 80331 | PubTator's text mining | https://conductscience.org/library/genes/80331 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| PLP1 | 5354 | PubTator's text mining | https://conductscience.org/library/genes/5354 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35697668
GET https://conductscience.org/api/papers/v1/35697668/references?page=2